회사 소개
- 법인명: Hubei Biocause Heilen Pharmaceutical Co., Ltd
- 등록 국가: China
- 주소: C-7th Floor, Golden trade center, Guantong Garden, 115 Wujiadun Road, Jianghan...
- 직원 수: 1000 - 4999
- 설립 연도: 1993
설명:
Hubei Biocause Pharma is a leading API producer in China with two API sites and one R&D center, inspected and approved 9 times by the US FDA and 3 times under EU GMP. The company produces abiraterone acetate, ibuprofen, milrinone, fludarabine phosphate, granisetron HCl, flumazenil, ibuprofen arginine, ibuprofen lysinate, dexibuprofen, cladribine, carfilzomib, torasemide, dexmedetomidine HCl, docusate sodium and indocyanine green, exporting to more than 90 countries, with about half sold into regulated markets such as the USA and EU.
사업 활동
원료의약품(API)
제조업체
계약 및 아웃소싱 서비스
제조업체
ATC 분류체계 (해부치료화학분류)
제조업체
오리지널 원료의약품
제조업체
당사 제품 & 서비스
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
인증
ISO 17020
DMF
FDA
GMP
증거
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기